Product Name: Exenatide
CAS No: 141758-74-9
Molar Mass: 4186.57
Chemical Formula: C184H282N50O60S
Synonyms: AC 2993, Bydureon, DA 3091
Storage: Store at -20℃
Sequence: HGEGTFTSDL SKQMEEEAVR LFIEWLKNGG PSSGAPPPS
Target: GLP-1 RA
Application: Exenatide (CAS number 141758-74-9) is a pivotal pharmaceutical compound employed in the treatment of type 2 diabetes, belonging to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Administered via injection, Exenatide mimics endogenous GLP-1, enhancing glucose-dependent insulin secretion and suppressing glucagon release, resulting in improved blood glucose control. This dual mechanism makes it particularly valuable for individuals not achieving sufficient glycemic control with oral antidiabetic medications alone. Beyond its primary role in glycemic management, Exenatide has shown promise in conferring cardiovascular benefits, further enhancing its therapeutic profile. In the pharmaceutical landscape, Exenatide is recognized for its efficacy in improving glucose homeostasis, positioning it as a valuable component in the comprehensive care of patients with type 2 diabetes.
